海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300584 海辰药业

未开盘 03-16 09:30:00

{"stockData":{"symbol":"300584","market":"SZ","secType":"STK","nameCN":"海辰药业","latestPrice":44.85,"timestamp":1773623331000,"preClose":44.85,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":82110700,"shares":120000000,"eps":0.3732,"marketStatus":"未开盘","change":0,"latestTime":"03-16 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.3732,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773624600000},"marketStatusCode":0,"adr":0,"adjPreClose":44.85,"symbolType":"stock","openAndCloseTimeList":[[1773624600000,1773631800000],[1773637200000,1773644400000]],"highLimit":49.34,"lowLimit":40.37,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120000000,"isCdr":false,"pbRate":5.16,"roa":"--","peRate":120.176849,"roe":"3.16%","epsLYR":0.3351,"committee":0,"marketValue":5382000000,"turnoverRate":0,"status":2,"floatMarketCap":3683000000},"requestUrl":"/m/hq/s/300584","defaultTab":"news","newsList":[{"id":"2619316294","title":"3月13日海辰药业涨5.13%，中信建投低碳成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619316294","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619316294?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:26","pubTimestamp":1773390411,"startTime":"0","endTime":"0","summary":"证券之星消息，3月13日海辰药业涨5.13%，收盘报44.85元，换手率10.33%，成交量8.48万手，成交额3.8亿元。重仓海辰药业的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为中信建投基金的中信建投低碳成长混合A。中信建投低碳成长混合A目前规模为1.86亿元，最新净值0.5774，较上一交易日下跌1.08%，近一年上涨18.73%。该公募基金现任基金经理为周紫光。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300027331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","601066","300584","BK0239"],"gpt_icon":0},{"id":"2614162810","title":"海辰药业(300584)2月13日股东户数2.11万户，较上期减少0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614162810","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614162810?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:18","pubTimestamp":1772097510,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海辰药业披露，截至2026年2月13日公司股东户数为2.11万户，较1月30日减少14.0户，减幅为0.07%。在化学制药行业个股中，海辰药业股东户数低于行业平均水平，截至2月13日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年1月30日至2026年2月13日，海辰药业区间跌幅为2.96%，在此期间股东户数减少14.0户，减幅为0.07%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600026158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2608843949","title":"海辰药业：截至1月30日收盘，公司股东户数为21,149户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608843949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608843949?lang=zh_cn&edition=full","pubTime":"2026-02-03 11:33","pubTimestamp":1770089602,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，公司截止1月30日最新的股东人数是多少？海辰药业回复：尊敬的投资者您好，截至1月30日收盘，公司股东户数为21,149户，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300016053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2608886483","title":"股市必读：海辰药业（300584）1月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2608886483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608886483?lang=zh_cn&edition=full","pubTime":"2026-02-02 02:27","pubTimestamp":1769970431,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，海辰药业报收于44.94元，上涨1.33%，换手率5.91%，成交量4.86万手，成交额2.21亿元。董秘最新回复投资者： 你好，请问贵公司什么时候公布25年业绩预告？董秘： 尊敬的投资者您好，公司2025年度报告已预约至2026年4月25日对外披露，感谢对海辰药业的关注！当日关注点来自交易信息汇总：1月30日主力资金净流入1555.43万元，显示主力对个股短期态度积极。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2606921796","title":"1月28日海辰药业跌5.39%，中信建投低碳成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606921796","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606921796?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:42","pubTimestamp":1769589754,"startTime":"0","endTime":"0","summary":"证券之星消息，1月28日海辰药业跌5.39%创60日新低，收盘报45.78元，换手率8.21%，成交量6.74万手，成交额3.13亿元。重仓海辰药业的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为中信建投基金的中信建投低碳成长混合A。中信建投低碳成长混合A目前规模为1.86亿元，最新净值0.6069，较上一交易日下跌0.74%，近一年上涨24.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800027723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584","601066","BK0276"],"gpt_icon":0},{"id":"2603667234","title":"海辰药业：截至2026年1月9日股东数为21,073户","url":"https://stock-news.laohu8.com/highlight/detail?id=2603667234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603667234?lang=zh_cn&edition=full","pubTime":"2026-01-14 15:05","pubTimestamp":1768374319,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，公司最新的股东人数是多少海辰药业回复：尊敬的投资者您好，截至2026年1月9日，公司股东数为21,073户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400019939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2601526388","title":"股市必读：海辰药业（300584）1月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601526388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601526388?lang=zh_cn&edition=full","pubTime":"2026-01-08 01:56","pubTimestamp":1767808573,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，海辰药业报收于52.53元，下跌1.26%，换手率5.21%，成交量4.28万手，成交额2.26亿元。四川洛辰是公司控股子公司安庆汇辰与赛科动力的合资公司，双方一直在固态电池粘结剂的小试开发上紧密合作，该项目目前还处于小试开发阶段。感谢对海辰药业的关注！交易信息汇总资金流向1月7日主力资金净流出859.85万元；游资资金净流出1210.01万元；散户资金净流入2069.86万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800000951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2601282555","title":"海辰药业：硫化锂中试线产品参数达标即将送样","url":"https://stock-news.laohu8.com/highlight/detail?id=2601282555","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601282555?lang=zh_cn&edition=full","pubTime":"2026-01-07 11:34","pubTimestamp":1767756876,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业01月07日在投资者关系平台上答复投资者关心的问题。投资者提问：王总您好，近期硫化物固态电池产业化加速，公司两个领域的进展备受市场关注：1. 硫化锂方面：请问目前中试产能利用率、产品纯度？感谢对海辰药业的关注！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700013848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2601876978","title":"海辰药业（300584）披露控股股东、实际控制人股份全部解除质押公告，1月5日股价上涨3.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601876978","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601876978?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:27","pubTimestamp":1767623237,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，海辰药业报收于52.01元，较前一交易日上涨3.56%，最新总市值为62.41亿元。该股当日开盘50.34元，最高52.2元，最低50.34元，成交额达2.88亿元，换手率为6.79%。公司于近日发布公告称，控股股东、实际控制人之一、董事长曹于平先生已将其所持有的4,000,000股公司股份全部解除质押，占其所持股份比例7.92%，占公司总股本比例3.33%。相关解除质押手续已办理完毕，质权人为中国银河证券股份有限公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500040162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2594535142","title":"股市必读：海辰药业（300584）12月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2594535142","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594535142?lang=zh_cn&edition=full","pubTime":"2025-12-26 01:36","pubTimestamp":1766684180,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，海辰药业报收于51.25元，下跌1.25%，换手率5.28%，成交量4.34万手，成交额2.24亿元。董秘最新回复投资者： 请问vc生产准备工作是否已经完成？希望贵公司能充分发挥现有优势，抓紧一切时间尽快投产董秘： 尊敬的投资者您好，公司VC项目已开始试生产，尚需经历产能爬坡过程。感谢对海辰药业的关注！当日关注点来自交易信息汇总：12月25日主力资金净流出2170.38万元，散户资金净流入1718.64万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600000516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2594816472","title":"海辰药业：VC项目已开始试生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2594816472","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594816472?lang=zh_cn&edition=full","pubTime":"2025-12-25 11:33","pubTimestamp":1766633623,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)12月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问vc生产准备工作是否已经完成？希望贵公司能充分发挥现有优势，抓紧一切时间尽快投产海辰药业回复：尊敬的投资者您好，公司VC项目已开始试生产，尚需经历产能爬坡过程。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500013582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2589591338","title":"海辰药业(300584.SZ)：公司注射用盐酸兰地洛尔被纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589591338","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589591338?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:06","pubTimestamp":1765181211,"startTime":"0","endTime":"0","summary":"海辰药业(300584.SZ)公告，据国家医保局、人力资源社会保障部发布《关于印发&lt;国家基本医疗保险、生育保险和工伤保险药品目录&gt;以及&lt;商业健康保险创新药品目录&gt;(2025年)的通知》，公司注射用盐酸兰地洛尔(50mg)续约成功,注射用盐酸兰地洛尔(150mg)首次纳入《国家基本医疗保险、工伤保险和生育保险药品目录(2025年)》。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/astock/8.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/8.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2589338651","title":"海辰药业：截至2025年11月28日股东总户数25,768户","url":"https://stock-news.laohu8.com/highlight/detail?id=2589338651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589338651?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:00","pubTimestamp":1765180825,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)12月08日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2025年11月30日，公司股东人数总数是多少？谢谢！海辰药业回复：尊敬的投资者您好，截止至2025年11月28日，公司股东总户数25,768户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800013883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2588095747","title":"海辰药业：截至11月20日股东数为25776户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588095747","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588095747?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:27","pubTimestamp":1764577626,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2025年11月20日，公司股东人数总数是多少？谢谢！海辰药业回复：尊敬的投资者您好，截至11月20日，公司股东数为25776户。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100016888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2588747064","title":"海辰药业：与四川赛科动力合作开发粘结剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2588747064","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588747064?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:25","pubTimestamp":1764577524,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司和四川赛科动力合作开发的粘结剂主要是为了解决固态电解质和正负极之间的界面接触问题吗？固固接触问题被认为固态电池技术的关键难题，目前公司粘结剂技术成果进展如何？海辰药业回复：尊敬的投资者您好，公司与四川赛科动力合作开发的粘结剂主要解决固固接触及相关副反应问题，目前正在小试产品定型阶段。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100016702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2588747100","title":"海辰药业：VC项目进行投产前准备工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2588747100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588747100?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576916,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司已建6000吨VC和3000吨FEC产线的现状，是否已经投产，何时可以投产？另外，请问贵司硫化物电解质的送样进展？谢谢海辰药业回复：尊敬的投资者您好，公司VC项目正在进行投产前准备工作，硫化锂项目正在进行中试试生产。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100015668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2584160738","title":"海辰药业：综合分析相关投产计划安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2584160738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584160738?lang=zh_cn&edition=full","pubTime":"2025-11-18 11:33","pubTimestamp":1763436838,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)11月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问市场环境现在如此好，为什么VC产线不投产，是装置有问题吗？请董秘认真回答一下！海辰药业回复：尊敬的投资者您好，公司正在综合分析考虑相关投产计划安排，是否投产受当前市场环境，行业趋势，供需关系，自身产能等因素影响。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800014286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2583022625","title":"海辰药业：公司电解液添加剂详细产能可见公司历年定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2583022625","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583022625?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:10","pubTimestamp":1763129400,"startTime":"0","endTime":"0","summary":"证券日报网讯海辰药业11月14日在互动平台回答投资者提问时表示，公司电解液添加剂详细产能可见公司历年定期报告，目前主要给国内主要电解液厂供货。固态电池方面主要在硫化锂及粘结剂方面有所布局，详细情况可参见公司定期报告。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxktks4243345.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxktks4243345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2583579075","title":"11月14日海辰药业（300584）龙虎榜数据：游资上海中山东路上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2583579075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583579075?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:33","pubTimestamp":1763112814,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月14日公布的交易公开信息显示，海辰药业因日涨幅达到15%的前5只证券，连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年11月14日收盘，海辰药业报收于71.9元，上涨19.99%，涨停，换手率26.19%，成交量21.5万手，成交额14.17亿元。上海中山东路等知名游资榜上有名。从龙虎榜公布的三日买卖数据来看，机构合计净买入3558.87万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400028282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2583572579","title":"海辰药业最新公告：公司目前经营正常不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2583572579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583572579?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:17","pubTimestamp":1763111822,"startTime":"0","endTime":"0","summary":"海辰药业(300584.SZ)公告称，公司股票交易价格连续两个交易日收盘价格涨幅偏离值累计超过30%，属于股票交易异常波动情况。经核实，公司前期披露的信息不存在需要更正、补充之处，近期经营情况正常，内外部经营环境未发生重大变化。公司、控股股东和实际控制人不存在关于本公司的应披露而未披露的重大事项，也不存在处于筹划阶段的重大事项。控股股东和实际控制人在股票交易异常波动期间不存在买卖公司股票的情形。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400027435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773623363200,"stockEarnings":[{"period":"1week","weight":0.0508},{"period":"1month","weight":0.0149},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.337},{"period":"1year","weight":1.35},{"period":"ytd","weight":-0.1069}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0088},{"period":"3month","weight":0.053},{"period":"6month","weight":0.0581},{"period":"1year","weight":0.2193},{"period":"ytd","weight":0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京海辰药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"21135人(较上一季度减少0.07%)","perCapita":"3885股","listingDate":"2017-01-12","address":"江苏省南京市栖霞区经济技术开发区恒发路1号","registeredCapital":"12000万元","survey":"　　南京海辰药业股份有限公司的主营业务是化学制剂、原料药及中间体的研发、生产、销售。公司的主要产品是心脑血管类、抗感染类、利尿类、消化类、免疫调节类、其他类。","listedPrice":11.11},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海辰药业,300584,海辰药业股票,海辰药业股票老虎,海辰药业股票老虎国际,海辰药业行情,海辰药业股票行情,海辰药业股价,海辰药业股市,海辰药业股票价格,海辰药业股票交易,海辰药业股票购买,海辰药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}